Published in Hepatitis Weekly, May 15th, 1995
"It also outlines the need for optimization of cloning strategies to limit sequence-interference between determinants of interest that may ultimately minimize antigen presentations and thus the immune response," indicated Genevieve Inchauspe, Ph.D., INSERM, Lyon, France, in her presentation abstract at the Hepatitis - Latest Advances in the Diagnosis, Prevention and Treatment of HBV and HCV meeting April 20-21, 1995, in Washington,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.